Balancing Cost and Care: Covering GLP-1s for Weight Management

The growing demand for GLP-1s like Wegovy to treat weight management is causing many employers to reconsider their benefits plans.

While less than one-fifth of organizations with more than 200 employees currently cover GLP-1s, almost half of Americans are interested in weight-loss medications. And, many are making decisions to stay or to leave a job based on whether the coverage is offered.

With costs for GLP-1s being a significant hurdle, HR leaders need to balance financial responsibility and workforce well-being. RxBenefits’ Chief Pharmacy Officer, Mark Campbell, shares how human-led strategies like prior authorization, step therapy, and customized, tiered cost-sharing can ensure employees receive the right care in this HR Executive article.